Latest Financials News

Dominion Investment Group Limited has announced an offer of up to $500 million in unsecured, deferrable, redeemable floating rate notes, aiming to provide investors with monthly income and ASX listing under ticker DMNHA.

Finbar Group Limited’s 2025 AGM confirmed strong shareholder support for key resolutions as the company reported record sales and unveiled a robust $1.2 billion development pipeline focused on mid-market apartments in Perth.

VHM Limited has secured a significant offtake framework with Mitsui and a US$200 million financing interest from the US Export-Import Bank for its Goschen Rare Earths and Mineral Sands Project, alongside key environmental approvals. These milestones set the stage for a Final Investment Decision in the first half of 2026.

ActivEX Limited has completed a significant $800,000 share placement to True Creation Limited, aiming to strengthen its financial footing and advance exploration projects.

Vectus Biosystems has temporarily paused trading of its securities pending a forthcoming announcement, signaling potential material news for investors.

QBE Insurance Group has announced the redemption of its USD 300 million 6.10% fixed rate subordinated notes due 2045, marking a notable step in its capital management strategy with regulatory approval secured.

NSX Limited confirms the legal effectiveness of its acquisition by a Canadian entity, with trading suspended and shareholder payments scheduled.

Southern Cross Gold Consolidated Ltd. reported a net loss of $925,512 for Q1 2026, alongside significant progress in its Australian gold-antimony projects and key corporate milestones including TSX main board graduation.

Aerometrex reports a robust first quarter with a 42.75% annualised rise in MetroMap subscription revenue, a significant 3D project contract in the US, and a 52% jump in LiDAR sales, underpinning its strategic momentum.

Matsa Resources has officially commenced gold production at its Devon Pit Gold Mine, marking a pivotal step in its Lake Carey Gold Project. The company also advances its AngloGold Option Agreement and outlines ambitious exploration and development plans.

Bod Science reports a $576k cash outflow in Q1 FY2026 amid ongoing administration and delays in Biortica audit completion. The company plans a shareholder vote in November to approve its acquisition of Biortica and exit from administration.

Bod Science Limited reported a $576,000 net operating cash outflow for the September quarter, sustained by funding from Biortica Agrimed Limited under a Deed of Company Arrangement as it pursues a backdoor listing.